Issued Patents 2022
Showing 1–14 of 14 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 11498954 | Modified monocytes/macrophage expressing chimeric antigen receptors and uses thereof | Saar Gill, Michael Klichinsky | 2022-11-15 |
| 11484552 | Use of trans-signaling approach in chimeric antigen receptors | Daniel J. Powell, Jr. | 2022-11-01 |
| 11471487 | Compositions and methods of stimulating and expanding T cells | Yangbing Zhao, Xiaojun Liu | 2022-10-18 |
| 11459390 | Phosphoglycerate kinase 1 (PGK) promoters and methods of use for expressing chimeric antigen receptor | Jennifer Brogdon, Hilmar Erhard Ebersbach, David Glass, Thomas Huber, Julia Jascur +11 more | 2022-10-04 |
| 11407805 | Modified monocytes/macrophage expressing chimeric antigen receptors and uses thereof | Saar Gill, Michael Klichinsky | 2022-08-09 |
| 11359002 | Modified monocytes/macrophage expressing chimeric antigen receptors and uses thereof | Saar Gill, Michael Klichinsky | 2022-06-14 |
| 11332511 | Modified monocytes/macrophage expressing chimeric antigen receptors and uses thereof | Saar Gill, Michael Klichinsky | 2022-05-17 |
| 11325963 | Modified monocytes/macrophage expressing chimeric antigen receptors and uses thereof | Saar Gill, Michael Klichinsky | 2022-05-10 |
| 11319358 | Modified monocytes/macrophage expressing chimeric antigen receptors and uses thereof | Saar Gill, Michael Klichinsky | 2022-05-03 |
| 11306134 | Modified monocytes/macrophage expressing chimeric antigen receptors and uses thereof | Saar Gill, Michael Klichinsky | 2022-04-19 |
| 11306133 | Modified monocytes/macrophage expressing chimeric antigen receptors and uses thereof | Saar Gill, Michael Klichinsky | 2022-04-19 |
| 11299536 | Compositions and methods for generating a persisting population of T cells useful for the treatment of cancer | Matthew J. Frigault, Yangbing Zhao, John Scholler | 2022-04-12 |
| 11274298 | RNA engineered T cells for the treatment of cancer | Yangbing Zhao | 2022-03-15 |
| 11273219 | Toxicity management for anti-tumor activity of CARs | Bruce L. Levine, Michael D. Kalos, Stephan Grupp | 2022-03-15 |